Xeltis’ RestoreX technology platform won Gold for Testing & Treatment Options at the 2017 Edison Awards Gala in New York City Thursday night. The global awards recognize persistence and excellence in innovation and are at their 30th edition.

The RestoreX proprietary technology platform is truly disruptive in cardiovascular treatment, the jury concludes. Xeltis’ heart valves and blood vessels enable the patient’s body to naturally restore a new heart valve or blood vessel before being absorbed in the body.

Subscribe to IO on Telegram!

Want to be inspired 365 days per year? Here’s the opportunity. We offer you one "origin of innovation" a day in a compact Telegram message. Seven days a week, delivered around 8 p.m. CET. Straight from our newsroom. Subscribe here, it's free!

Subscribe!

“We are honored the Edison Award recognized the truly innovative potential of our technology. We are making happen something that sounded impossible: enabling the body to restore its own heart valves and patients to live better lives soon,” Xeltis CEO Laurent Grandidier said.

Learn more about the Gold-winning Edison Award RestoreX technology here.

(Source: press release Xeltis)

“Xeltis is truly disruptive in cardiovascular treatment”,

Support us!

Innovation Origins is an independent news platform that has an unconventional revenue model. We are sponsored by companies that support our mission: to spread the story of innovation. Read more.

At Innovation Origins, you can always read our articles for free. We want to keep it that way. Have you enjoyed our articles so much that you want support our mission? Then use the button below:

Doneer

Personal Info

About the author

Author profile picture Bart Brouwers is co-founder and co-owner of Media52 BV, the publisher of innovationorigins.com.